427 A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced melanoma

427 A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced melanoma

Bibliographic Details
Main Authors: Mohammed Milhem, Yousef Zakharia, Jayanshu Jain, Melanie Frees, Hesham Yasin, Jaime Bonner, Michele Freesmeier, Rohan Garje, Vyshak Alva Venur
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer
id doaj-702f0761c1b842639ed3cdce5eb7cb53
record_format Article
spelling doaj-702f0761c1b842639ed3cdce5eb7cb532020-12-11T10:01:58ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.0427427 A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced melanomaMohammed Milhem0Yousef Zakharia1Jayanshu Jain2Melanie Frees3Hesham Yasin4Jaime Bonner5Michele Freesmeier6Rohan Garje7Vyshak Alva Venur8Aff10 grid.214572.70000000419368294University of Iowa Iowa City IA USA Medical Oncology, University of Iowa Holden Comprehensive Cancer Center, Iowa City, Iowa, USAUniversity of Iowa Hospitals and Clinics, Iowa City, IA, USAUniversity of Iowa Hospitals and Clinics, Iowa City, IA, USAUniversity of Iowa Hospitals and Clinics, Iowa City, IA, USAUniversity of Iowa Hospitals and Clinics, Iowa City, IA, USAUniversity of Iowa Hospitals and Clinics, Iowa City, IA, USAUniversity of Iowa Hospitals and Clinics, Iowa City, IA, USAUniversity of Iowa Hospitals and Clinics, Iowa City, IA, USA
collection DOAJ
language English
format Article
sources DOAJ
author Mohammed Milhem
Yousef Zakharia
Jayanshu Jain
Melanie Frees
Hesham Yasin
Jaime Bonner
Michele Freesmeier
Rohan Garje
Vyshak Alva Venur
spellingShingle Mohammed Milhem
Yousef Zakharia
Jayanshu Jain
Melanie Frees
Hesham Yasin
Jaime Bonner
Michele Freesmeier
Rohan Garje
Vyshak Alva Venur
427 A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced melanoma
Journal for ImmunoTherapy of Cancer
author_facet Mohammed Milhem
Yousef Zakharia
Jayanshu Jain
Melanie Frees
Hesham Yasin
Jaime Bonner
Michele Freesmeier
Rohan Garje
Vyshak Alva Venur
author_sort Mohammed Milhem
title 427 A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced melanoma
title_short 427 A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced melanoma
title_full 427 A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced melanoma
title_fullStr 427 A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced melanoma
title_full_unstemmed 427 A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced melanoma
title_sort 427 a phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced melanoma
publisher BMJ Publishing Group
series Journal for ImmunoTherapy of Cancer
issn 2051-1426
publishDate 2020-11-01
work_keys_str_mv AT mohammedmilhem 427aphase1b2studyofcabozantinibincombinationwithpembrolizumabinadvancedmelanoma
AT yousefzakharia 427aphase1b2studyofcabozantinibincombinationwithpembrolizumabinadvancedmelanoma
AT jayanshujain 427aphase1b2studyofcabozantinibincombinationwithpembrolizumabinadvancedmelanoma
AT melaniefrees 427aphase1b2studyofcabozantinibincombinationwithpembrolizumabinadvancedmelanoma
AT heshamyasin 427aphase1b2studyofcabozantinibincombinationwithpembrolizumabinadvancedmelanoma
AT jaimebonner 427aphase1b2studyofcabozantinibincombinationwithpembrolizumabinadvancedmelanoma
AT michelefreesmeier 427aphase1b2studyofcabozantinibincombinationwithpembrolizumabinadvancedmelanoma
AT rohangarje 427aphase1b2studyofcabozantinibincombinationwithpembrolizumabinadvancedmelanoma
AT vyshakalvavenur 427aphase1b2studyofcabozantinibincombinationwithpembrolizumabinadvancedmelanoma
_version_ 1724386572702318592

Similar Items